Current Treatments for Alopecia Areata

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations


Selection of a therapy for a patient with alopecia areata (AA) is frequently based on the age of the patient, disease extent, perhaps disease duration, patient expectations, cost of therapy in terms of time commitment, and financial resources, as well as the results of screening laboratory studies that rule out the presence of other co-morbidities such as anemia, low iron stores, thyroid abnormalities, low Vitamin D, or other autoimmune diseases. Although there is currently no cure for AA and no universally proven therapy that induces and sustains remission, many therapies are available which can be of benefit to both affected children and adults. Before selecting a treatment for patients with extensive long-standing AA, a scalp biopsy may provide useful information about the degree of inflammation and follicle differentiation. Recent clinical and translational research observations with the systemic Janus kinase (JAK) inhibitors and interleukin-2 (IL-2) have excited the clinical and AA patient communities and have led to clinical trials, as well as to the off-label use of these more expensive and targeted systemic therapies.

Original languageEnglish (US)
Pages (from-to)44-46
Number of pages3
JournalJournal of Investigative Dermatology Symposium Proceedings
Issue number2
StatePublished - Nov 1 2015

Bibliographical note

Funding Information:
Funding for the Summit and the publication of this supplement was provided by the National Alopecia Areata Foundation and was made possible (in part) by a grant (R13AR067088-01) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases and all co-funding support was provided by the National Center for Advancing Translational Sciences.

Publisher Copyright:
© 2015 The Society for Investigative Dermatology.


Dive into the research topics of 'Current Treatments for Alopecia Areata'. Together they form a unique fingerprint.

Cite this